Results 101 to 110 of about 27,107 (181)

INCEPTUS Natural History, Run-in Study for Gene Replacement Clinical Trial in X-Linked Myotubular Myopathy. [PDF]

open access: yesJ Neuromuscul Dis, 2022
Dowling JJ   +35 more
europepmc   +1 more source

Some DNM2 mutations cause extremely severe congenital myopathy and phenocopy myotubular myopathy

open access: yesActa Neuropathologica Communications, 2018
Valérie Biancalana   +9 more
doaj   +1 more source

X-linked myotubular myopathy, liver disease, and gene therapy. [PDF]

open access: yesJ Neuromuscul Dis
Pannia E   +3 more
europepmc   +1 more source

Estimation of the Quality-of-Life Impact of X-Linked Myotubular Myopathy. [PDF]

open access: yesJ Neuromuscul Dis, 2021
Lloyd A   +5 more
europepmc   +1 more source

Diagnosing X-linked Myotubular Myopathy - A German 20-year Follow Up Experience. [PDF]

open access: yesJ Neuromuscul Dis, 2021
Gangfuss A   +6 more
europepmc   +1 more source

Pharmacological PIK3C2B inhibition rescues XLMTM phenotype in mouse models and identifies molecular markers of disease

open access: yesJCI Insight
X-linked myotubular myopathy (XLMTM) is a rare genetic disorder that typically presents at birth with progressive muscle weakness and respiratory difficulties and is caused by myotubularin 1 (MTM1) gene mutations.
Andrew Shearer   +10 more
doaj   +1 more source

X-Linked Myotubular Myopathy: A Novel Mutation Expanding the Genotypic Spectrum of a Phenotypically Heterogeneous Myopathy. [PDF]

open access: yesJ Pediatr Genet, 2023
Carvalho A   +7 more
europepmc   +1 more source

Costs and health resource use in patients with X-linked myotubular myopathy: insights from US commercial claims. [PDF]

open access: yesJ Manag Care Spec Pharm, 2021
Sacks NC   +6 more
europepmc   +1 more source

Potential compensatory mechanisms preserving cardiac function in myotubular myopathy. [PDF]

open access: yesCell Mol Life Sci
Simon A   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy